Cargando…
Relowering of Serum Na for Osmotic Demyelinating Syndrome
We report a case in whom slow correction of hyponatremia (5 mmol/day for 3 days) induced central pontine myelinolysis (CPM). After the diagnosis was confirmed by imaging, we started to relower serum Na that completely recovered the sign and symptoms of CPM. Rapid correction of serum sodium is known...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3420698/ https://www.ncbi.nlm.nih.gov/pubmed/22937357 http://dx.doi.org/10.1155/2012/704639 |
_version_ | 1782240903412318208 |
---|---|
author | Yamada, Hideomi Takano, Koji Ayuzawa, Nobuhiro Seki, George Fujita, Toshiro |
author_facet | Yamada, Hideomi Takano, Koji Ayuzawa, Nobuhiro Seki, George Fujita, Toshiro |
author_sort | Yamada, Hideomi |
collection | PubMed |
description | We report a case in whom slow correction of hyponatremia (5 mmol/day for 3 days) induced central pontine myelinolysis (CPM). After the diagnosis was confirmed by imaging, we started to relower serum Na that completely recovered the sign and symptoms of CPM. Rapid correction of serum sodium is known to be associated with CPM. However, it may occur even after slow correction of hyponatremia. Currently, there is no standard therapy for CPM other than supportive therapy. Other therapy includes sterioid, plasmaphresis and IVIG, but these therapies have not been shown to be particularly effective. The pathophysiology of CPM is related to a relative dehydration of the brain during the correction of hyponatremia, resulting in cell death and demyelination, therefore gentle rehydration with lowering serum sodium may not be an unreasonable therapy. The present case provides supportive evidence that reinduction of hyponatremia is effective in treating CPM if started immediately after the diagnosis is suggested. The present case tells us that severe chronic hyponatremia must be managed with extreme care especially in patients with chronic debilitating illness and that relowering serum Na is a treatment of choice when CPM is suggested. |
format | Online Article Text |
id | pubmed-3420698 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-34206982012-08-30 Relowering of Serum Na for Osmotic Demyelinating Syndrome Yamada, Hideomi Takano, Koji Ayuzawa, Nobuhiro Seki, George Fujita, Toshiro Case Rep Neurol Med Case Report We report a case in whom slow correction of hyponatremia (5 mmol/day for 3 days) induced central pontine myelinolysis (CPM). After the diagnosis was confirmed by imaging, we started to relower serum Na that completely recovered the sign and symptoms of CPM. Rapid correction of serum sodium is known to be associated with CPM. However, it may occur even after slow correction of hyponatremia. Currently, there is no standard therapy for CPM other than supportive therapy. Other therapy includes sterioid, plasmaphresis and IVIG, but these therapies have not been shown to be particularly effective. The pathophysiology of CPM is related to a relative dehydration of the brain during the correction of hyponatremia, resulting in cell death and demyelination, therefore gentle rehydration with lowering serum sodium may not be an unreasonable therapy. The present case provides supportive evidence that reinduction of hyponatremia is effective in treating CPM if started immediately after the diagnosis is suggested. The present case tells us that severe chronic hyponatremia must be managed with extreme care especially in patients with chronic debilitating illness and that relowering serum Na is a treatment of choice when CPM is suggested. Hindawi Publishing Corporation 2012 2012-06-28 /pmc/articles/PMC3420698/ /pubmed/22937357 http://dx.doi.org/10.1155/2012/704639 Text en Copyright © 2012 Hideomi Yamada et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Report Yamada, Hideomi Takano, Koji Ayuzawa, Nobuhiro Seki, George Fujita, Toshiro Relowering of Serum Na for Osmotic Demyelinating Syndrome |
title | Relowering of Serum Na for Osmotic Demyelinating Syndrome |
title_full | Relowering of Serum Na for Osmotic Demyelinating Syndrome |
title_fullStr | Relowering of Serum Na for Osmotic Demyelinating Syndrome |
title_full_unstemmed | Relowering of Serum Na for Osmotic Demyelinating Syndrome |
title_short | Relowering of Serum Na for Osmotic Demyelinating Syndrome |
title_sort | relowering of serum na for osmotic demyelinating syndrome |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3420698/ https://www.ncbi.nlm.nih.gov/pubmed/22937357 http://dx.doi.org/10.1155/2012/704639 |
work_keys_str_mv | AT yamadahideomi reloweringofserumnaforosmoticdemyelinatingsyndrome AT takanokoji reloweringofserumnaforosmoticdemyelinatingsyndrome AT ayuzawanobuhiro reloweringofserumnaforosmoticdemyelinatingsyndrome AT sekigeorge reloweringofserumnaforosmoticdemyelinatingsyndrome AT fujitatoshiro reloweringofserumnaforosmoticdemyelinatingsyndrome |